Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Surufatinib Plus Toripalimab in Patients with Advanced Neuroendocrine Tumours and Neuroendocrine Carcinomas: an Open-Label, Single-Arm, Multi-Cohort Phase II Trial

Panpan Zhang,Si Shi,Jianming Xu,Zhendong Chen,Lijie Song,Xing Zhang,Ying Cheng,Yanqiao Zhang,Feng Ye,Zhiping Li,Fei Yin,Dongmei Ji,Heli Gao,Yi Li,Wei Chen,Minjie Yang,Desheng Weng,Chunjiao Wu,Yue Ma,Wang Sheng,Yaqin Zhao,Xiaolei Yin,Weina Shen,Weiguo Su,Michael Shi,Songhua Fan,Panfeng Tan, Qian Xu, Min Lu,Lin Shen

European Journal of Cancer（2024）

Cited 4|Views82
Key words
Surufatinib,Toripalimab,Neuroendocrine tumour,Neuroendocrine carcinoma,Mixed neuroendocrine non-neuroendocrine neoplasms,NET,NEC,Anti-PD1
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined